-
Mashup Score: 1Decipher Scores and PSMA PET Imaging: A Correlative Study in High-Risk Prostate Cancer - Amar Kishan - 5 month(s) ago
Daniel Spratt engages with Amar Kishan about the role of transcriptomic profiling and PSMA PET imaging in prostate cancer. Dr. Kishan discusses a study involving 18 trials and 12,500 patients, which suggests that extra-prostatic disease is often the driver of distant metastasis in high-risk patients. The study also explores the correlation between Decipher scores and the risk of upstaging on…
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 6Transcriptome-Based Prognostic and Predictive Biomarker Analysis - The DECIPHER Genomic Classifier for Prostate Cancer - Ashley Ross - 10 month(s) ago
Alicia Morgans and Ashley Ross discuss how the Decipher prognostic biomarker prostate classifier is being integrated into phase II and III clinical trials, a 22-gene prognostic biomarker that provides a score that indicates the aggressiveness of an individual patient’s cancer, to help healthcare professionals more accurately categorize risk and select appropriate treatment. The pair highlights…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Transcriptome-Based Prognostic and Predictive Biomarker Analysis - The DECIPHER Genomic Classifier for Prostate Cancer - Ashley Ross - 11 month(s) ago
Alicia Morgans and Ashley Ross discuss how the Decipher prognostic biomarker prostate classifier is being integrated into phase II and III clinical trials, a 22-gene prognostic biomarker that provides a score that indicates the aggressiveness of an individual patient’s cancer, to help healthcare professionals more accurately categorize risk and select appropriate treatment. The pair highlights…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0AUA 2023: Use of Decipher Prostate Biopsy Test in Men With Favorable Risk Disease Undergoing Conservative Management in the SEER Registry - 11 month(s) ago
AUA 2023, prostate cancer, Decipher Prostate Biopsy Test, The Surveillance Epidemiology and End Results (SEER) registry, favorable-risk prostate cancer, prostate cancer surveillance, radical prostatectomy.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 2Rationale for the Use of Decipher RP Genomic Classifier to Inform Treatment - Ashley Ross - 12 month(s) ago
Alicia Morgans and Ashley Ross discuss Decipher RP genomic classifier for prostatectomy specimens, and how to integrate these tests into clinical practice. Decipher is a genomic classifier that looks at the whole genome and expression patterns on that genome. The genomic classifier score is a prognostic score that goes from 0 to 1, and it was first developed to stratify the risk of metastatic…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 5Transcriptome-Based Prognostic and Predictive Biomarker Analysis - The DECIPHER Genomic Classifier for Prostate Cancer - Ashley Ross - 12 month(s) ago
Alicia Morgans and Ashley Ross discuss how the Decipher prognostic biomarker prostate classifier is being integrated into phase II and III clinical trials, a 22-gene prognostic biomarker that provides a score that indicates the aggressiveness of an individual patient’s cancer, to help healthcare professionals more accurately categorize risk and select appropriate treatment. The pair highlights…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Rationale for the Use of Decipher RP Genomic Classifier to Inform Treatment - Ashley Ross - 1 year(s) ago
Alicia Morgans and Ashley Ross discuss Decipher RP genomic classifier for prostatectomy specimens, and how to integrate these tests into clinical practice. Decipher is a genomic classifier that looks at the whole genome and expression patterns on that genome. The genomic classifier score is a prognostic score that goes from 0 to 1, and it was first developed to stratify the risk of metastatic…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1Transcriptome-Based Prognostic and Predictive Biomarker Analysis - The DECIPHER Genomic Classifier for Prostate Cancer - Ashley Ross - 1 year(s) ago
Alicia Morgans and Ashley Ross discuss how the Decipher prognostic biomarker prostate classifier is being integrated into phase II and III clinical trials, a 22-gene prognostic biomarker that provides a score that indicates the aggressiveness of an individual patient’s cancer, to help healthcare professionals more accurately categorize risk and select appropriate treatment. The pair highlights…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0
In this UroToday presentation Daniel Spratt, MD, and Alan Dal Pra, MD, share results from recent clinical trials that highlight the timing and patient selection for the personalization of hormone therapy with postoperative radiation therapy and the clinical implications for Decipher. Biographies: Daniel Spratt, MD, Vincent K. Smith Chair in Radiation Oncology, University Hospitals Seidman…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet-
Personalized hormone therapy with postoperative RT & validation of the #Decipher Genomic Classifier in SAKK 09/10. @DrSpratticus @caseccc and @a_dalpra @SylvesterCancer discussion on UroToday. #WatchNow > https://t.co/N0OCBTEzs6 @Decipher_VCYT @Veracyte @ashleyrossmdphd @SAKK_ch https://t.co/XmEcAm5m8h
-
-
Mashup Score: 1Rationale for the Use of Decipher RP Genomic Classifier to Inform Treatment - Ashley Ross - 1 year(s) ago
Alicia Morgans and Ashley Ross discuss Decipher RP genomic classifier for prostatectomy specimens, and how to integrate these tests into clinical practice. Decipher is a genomic classifier that looks at the whole genome and expression patterns on that genome. The genomic classifier score is a prognostic score that goes from 0 to 1, and it was first developed to stratify the risk of metastatic…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet
#Decipher scores and PSMA PET imaging: A correlative study in high-risk #ProstateCancer. @AmarUKishan @UCLA joins @DrSpratticus @caseccc to discuss the role of transcriptomic profiling and PSMA PET imaging in prostate cancer > https://t.co/bt51iKY23O @Decipher_VCYT @Veracyte https://t.co/3Cjo6HVi1b